These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12653944)

  • 1. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).
    Lee AH; Denley HE; Pinder SE; Ellis IO; Elston CW; Vujovic P; Macmillan RD; Evans AJ;
    Histopathology; 2003 Apr; 42(4):331-6. PubMed ID: 12653944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
    Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
    Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
    Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.
    Rakha EA; Ho BC; Naik V; Sen S; Hamilton LJ; Hodi Z; Ellis IO; Lee AH
    Histopathology; 2011 Mar; 58(4):626-32. PubMed ID: 21371081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
    Carder PJ; Liston JC
    J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
    Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
    BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
    Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.
    Hayes BD; O'Doherty A; Quinn CM
    J Clin Pathol; 2009 Dec; 62(12):1136-40. PubMed ID: 19946101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology.
    Noske A; Pahl S; Fallenberg E; Richter-Ehrenstein C; Buckendahl AC; Weichert W; Schneider A; Dietel M; Denkert C
    Hum Pathol; 2010 Apr; 41(4):522-7. PubMed ID: 20004938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions.
    Ibrahim AE; Bateman AC; Theaker JM; Low JL; Addis B; Tidbury P; Rubin C; Briley M; Royle GT
    J Clin Pathol; 2001 Feb; 54(2):121-5. PubMed ID: 11215280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3).
    Houssami N; Ciatto S; Bilous M; Vezzosi V; Bianchi S
    Br J Cancer; 2007 Apr; 96(8):1253-7. PubMed ID: 17438578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre.
    Kumaroswamy V; Liston J; Shaaban AM
    J Clin Pathol; 2008 Jun; 61(6):766-9. PubMed ID: 18326021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.
    Harvey JM; Sterrett GF; Frost FA
    Pathology; 2002 Oct; 34(5):410-6. PubMed ID: 12408338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
    Lucioni M; Rossi C; Lomoro P; Ballati F; Fanizza M; Ferrari A; Garcia-Etienne CA; Boveri E; Meloni G; Sommaruga MG; Ferraris E; Lasagna A; Bonzano E; Paulli M; Sgarella A; Di Giulio G
    Eur Radiol; 2021 Feb; 31(2):920-927. PubMed ID: 32816199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
    Rakha E; Beca F; D'Andrea M; Abbas A; Petrou-Nunn W; Shaaban AM; Kandiyil A; Smith S; Menon S; Elsheikh S; ElSayed ME; Lee AH; Sharma N
    J Clin Pathol; 2019 Dec; 72(12):800-804. PubMed ID: 31350292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B3 Breast Lesions: Positive Predictive Value and Follow-Up on a Large Single-Institution Series.
    Bernini M; Spolveri F; Tofani L; De Benedetto D; Bicchierai G; Bellini C; Morrone D; Nori Cucchiari J; Bianchi S; Livi L; Orzalesi L; Meattini I
    J Surg Res; 2024 Jul; 299():366-373. PubMed ID: 38815523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the British National Health Service Breast Cancer Screening Programme classification in 226 breast core needle biopsies: correlation with resected specimens.
    Pagni F; Bosisio FM; Salvioni D; Colombo P; Leone BE; Di Bella C
    Ann Diagn Pathol; 2012 Apr; 16(2):112-8. PubMed ID: 22056037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
    Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
    Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast core biopsy reporting categories--An internal validation in a series of 3054 consecutive lesions.
    Andreu FJ; Sáez A; Sentís M; Rey M; Fernández S; Dinarès C; Tortajada L; Ganau S; Palomar G
    Breast; 2007 Feb; 16(1):94-101. PubMed ID: 16982194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.